Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer?

Paul Brown, Matthew M. Clark, Pamela Atherton, Mashele Huschka, Jeff A. Sloan, Gail Gamble, Jean Girardi, Marlene H. Frost, Kate Piderman, Teresa A. Rummans

Research output: Contribution to journalArticlepeer-review

63 Scopus citations


BACKGROUND: Fatigue has a significant impact on the quality of life (QOL) of cancer patients. Recent research has suggested that physical activity can reduce fatigue in patients receiving active cancer treatment. In this project, we examined the impact that participation in a randomized controlled trial of a multidisciplinary intervention designed to impact overall QOL had on fatigue for advanced cancer patients actively receiving treatment. METHODS: Patients with newly diagnosed cancer were randomly assigned to an 8-session structured multidisciplinary intervention or a standard-care arm at the beginning of their course of radiotherapy (RT) designed to impact QOL. Ninety-minute sessions were led by either a psychiatrist or psychologist, collaborating with a nurse, physical therapist, chaplain, or social worker, depending on the session's theme. The fatigue assessments used in this trial included the Linear Analogue Self Assessment (LASA), the Profile of Mood States (POMS), Spielberger's State-Trait Anxiety Inventory (STAI), and the Symptom Distress Scale (SDS). RESULTS: There were 115 participants enrolled and the 2 randomization arms were well balanced in terms of baseline characteristics and treatment received except for increased commuting distance for the patients in the intervention arm (P = 0.042). Most of scores indicated less fatigue (higher score) in the standard treatment group, but there were no statistically significant differences found at baseline and weeks 4, 8, and 27 except for SDS at week 8 (P = 0.018) with less patients reporting significant fatigue in the standard treatment arm. For the entire participant population, fatigue levels initially worsened with radiotherapy, stabilized at week 8, and returned to baseline by week 27. Disease site, chemotherapy use, and radiotherapy dose did not have a significant impact on fatigue levels. CONCLUSIONS: Radiotherapy initially caused a worsening of fatigue but with time fatigue levels returned to baseline. Clinically, this structured multidisciplinary intervention had no impact on fatigue, and there was the suggestion the multiple sessions may have contributed to worse fatigue during active cancer treatment.

Original languageEnglish (US)
Pages (from-to)52-58
Number of pages7
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Issue number1
StatePublished - Feb 1 2006


  • Fatigue
  • Quality of life
  • Radiotherapy
  • Randomized controlled trials

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Will improvement in quality of life (QOL) impact fatigue in patients receiving radiation therapy for advanced cancer?'. Together they form a unique fingerprint.

Cite this